Draegerwerk Ag & Co. Kgaa · XETR:DRW8
Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — H1 2019 Earnings Presentation
20 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Aug 8, 2019
Slide 1: Conference call: Interim report January 1 to June 30, 2019
ICH WERDE DA SEIN. Conference call Interim report January 1 to June 30, 2019 Lübeck, August 8, 2019
Slide 2: Disclaimer
Disclaimer This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future d
Slide 3: Business Highlights 6M
Business Highlights 6M Net Sales Order intake growth (currency adjusted) in Q2 continued to be +2.0% +10.3% Currency positive: Currency 1,236 adjusted Q2 +2.9% yoy adjusted 6M +3.1% yoy 634 1,116 Gross profit margin below level of 620 last year: Q2 42.6% (-0.7pp yoy) Q2‘18 Q2‘19 6M'18 6M'19 6M 4
Slide 4: Order development in 6M
Order development in 6M Order entry (€ million) Net Sales Group Medical Safety Group America 262 +12.4% +9.2% +19.2% +22.1% Africa, Asia, -6.6% +20.8% +15.5% 347 +0.7% Australia Europe 711 +1.3% -3.7% +8.2% +4.4% Group 1,320 +3.1% -2.1% +12.4% +10.3% Growth rates are net of currency effects 4
Slide 5: Business development 6M
Business development 6M Q2 2018 Q2 2019 Change 6M 2018 6M 2019 Change € million € million % € million € million % Order Intake 652.3 672.8 3.1 1,273.8 1,320.4 3.7 % growth (FX adjusted) 1.4% 2.9% 2.0% 3.1% Net Sales 620.2 634.3 2.3 1,115.8 1,235.9 10.8 % growth (FX adjusted) 10.1% 2.0% 4.0% 10.3% Gr
Slide 6: Functional Expenses 6M
Functional Expenses 6M 6M 2018 6M 2019 Change Change net of FX € million € million % % R&D -127.9 -129.0 0.9 -0.5 % of Net Sales -11.5% -10.4% Sales & Marketing -284.6 -302.4 6.3 5.3 % of Net Sales -25.5% -24.5% Administration -99.9 -101.1 1.2 0.7 % of Net Sales -9.0% -8.2% SG&A -384.5 -403.5 4.9 4.
Slide 7: Key Figures 6M
Key Figures 6M 6M 2018 6M 2019 Change € million € million % Cashflow from operating activities -66.7 31.3 >100 Investments 34.8 60.6 74.0 Cash and cash equivalents1 139.4 150.2 7.8 Net financial debt1 78.8 171.2 >100 Net financial debt 1 /EBITDA 2 0.42 0.90 Capital employed 1 1,299.0 1,451.8 11.8 RO
Slide 8: Outlook
Outlook 2018 2019e Current forecast 3.9% +1.0 - +4.0 % Net sales Upper end of the range (net of currency effects) (net of currency effects) EBIT margin 2.4% 1.0 - 3.0 %1 Confirmed in the range EUR -60 to - Dräger Value Added EUR -26.5 million Confirmed 10 million 1 Based on exchange rates at the sta
Slide 9: Business units of the medical division
Business units of the medical division Products: Anesthesia, Ventilation, Thermo regulation equipment BU Therapy Focus: Core business with strong market share. Connectivity of devices. Products: Patient Monitors BU Monitoring Focus: Networked systems in cooperation with BU Therapy and IT & Systems.
Slide 10: Fields of the safety division
Business fields of the safety division Products: Mobile & Fixed Gas detection, Global rental & Oil & Gas Chemical Staffing services Pharma Power Processing Steel Fokus: Large national & global companies, Process & Industries asset managment, safety outcome, strategic key account management … Manufac
Slide 11: Questions & Answers
Questions & Answers Drager 11 Drager. Technik fiir das Leben®
Slide 12: Guidance 2019
Guidance 2019 2018 2019e Current forecast 3.9% +1.0 - +4.0 % Net sales Upper end of the range (net of currency effects) (net of currency effects) EBIT margin 2.4% 1.0 - 3.0 %1 Confirmed in the range EUR -60 to - Dräger Value Added EUR -26.5 million Confirmed 10 million Other forecast figures: on pri
Slide 13: IFRS 16 Impact
13 IFRS 16 Impact Drager EFFECTS OF THE APPLICATION OF IFRS 16 BEGINNING JANUARY 1, 2019 ON KEY FIGURES AS OF JUNE 30, 2019 Increase/improveme in € million nt as of June 30, 2019 EBITDA 22.7 EBIT 2.1 Cash flow from operating activities 20.6 Net financial debt 110.0 Investments 26.3 Capital employed
Slide 14: Business development quarter Segments
Business development quarter Segments Europe Americas Africa, Asia, Australia Dräger Group Q2 2018 Q2 2019 Q2 2018 Q2 2019 Q2 2018 Q2 2019 Q2 2018 Q2 2019 € million € million € million € million € million € million € million € million Order entry 365.1 362.4 117.5 140.4 169.7 169.9 652.3 672.8 Net S
Slide 15: Business development YTD Segments
Business development YTD Segments Europe Americas Africa, Asia, Australia Dräger Group 6M 2018 6M 2019 6M 2018 6M 2019 6M 2018 6M 2019 6M 2018 6M 2019 € million € million € million € million € million € million € million € million Order entry 706.6 711.3 228.0 262.2 339.1 346.8 1,273.8 1,320.4 Net S
Slide 16: Business development Medical
Business development Medical Q2 2018 Q2 2019 Change Change 6M 2018 6M 2019 Change Change € million € million % % (FX adj.) € million € million % % (FX adj.) Order entry 413.6 425.9 3.0 2.4 815.1 804.4 -1.3 -2.1 Europe 216.1 208.5 -3.5 -3.1 412.5 395.8 -4.0 -3.7 America 78.8 95.6 21.3 19.2 153.5 171.
Slide 17: Business development Safety
Business development Safety Q2 2018 Q2 2019 Change Change 6M 2018 6M 2019 Change Change € million € million % % (FX adj.) € million € million % % (FX adj.) Order entry 238.7 246.9 3.4 3.7 458.7 515.9 12.5 12.4 Europe 149.0 153.9 3.3 3.9 294.1 315.5 7.3 8.2 America 38.7 44.9 15.8 14.6 74.5 90.8 21.9
Slide 18: Cash-flow statement
Cash-flow statement 6M 2018 6M 2019 Change € million € million % Group net profit -29.3 -14.6 50.2 Change in inventories -86.1 -61.5 28.6 Change in receivables 82.1 116.1 41.4 Change in payables -28.3 -32.4 -14.7 Depreciation and amortization 42.5 59.9 40.9 Other operating cash flow items -47.6 -36.
Slide 19: Financial calendar 2019
Financial calendar 2019 March 7, 2019 - Final 2018 figures Conference call April 25, 2019 - Report for the first three months 2019 Conference call May 10, 2019 - Annual shareholders' meeting, Lübeck, Germany August 8, 2019 - Report for the first six months 2019 Conference call October 30, 2019 - Rep
Slide 20: Contact
Contact Melanie Kamann Thomas Fischler Corporate Communications Investor Relations Drägerwerk AG & Co. KGaA Drägerwerk AG & Co. KGaA Moislinger Allee 53−55 Moislinger Allee 53−55 23558 Lübeck, Germany 23558 Lübeck, Germany Tel +49 451 882-3998 Tel +49 451 882-2685 Fax +49 451 882-3944 Fax +49 451 88
Drägerwerk AG & Co. KGaA — H1 2019 Earnings Presentation on 6ix